Convergence technology in cancer medicine
Roger M Macklis1, Nidhi Sharma
1Department of Radiation Oncology, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. macklir@ccf.org
Convergence technology combines multiple medical devices and functionalities for enhanced healthcare. This innovation faces rigorous US FDA review, driving personalized medicine and market growth.
Area of Science:
- Technological innovation and medical device development.
- Integration of therapeutic, diagnostic, and digital health technologies.
Background:
- Convergence technology synthesizes multiple functionalities into single platforms, creating synergies.
- Medical device field sees novel combinations of therapeutic, diagnostic, and digital information technologies.
- Healthcare reform necessitates demonstrating comparative effectiveness of combined technologies.
Purpose of the Study:
- To define convergence technology within the medical device sector.
- To outline the evolving regulatory landscape for combination products.
- To summarize key elements driving value and personalized medicine.
Main Methods:
- Review of the concept and applications of convergence technology in medicine.
- Analysis of the regulatory framework, including the US FDA Office of Combination Products.
- Examination of market trends and the push towards personalized medicine.
Main Results:
- Convergence technology offers functional, operational, and economic synergies.
- Increased regulatory scrutiny from the US FDA for pre- and post-market safety reviews.
- Significant global market value in the tens of billions of dollars.
Conclusions:
- Convergence technology is a significant driver of innovation in healthcare.
- The regulatory environment is adapting to oversee these complex products.
- These advancements are crucial for delivering more personalized and effective medical treatments.
More Related Videos
10:25A Dorsal Skinfold Window Chamber Tumor Mouse Model for Combined Intravital Microscopy and Magnetic Resonance Imaging in Translational Cancer Research
Published on: April 12, 2024
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
